Omnicell, Inc. (OMCL)
- Previous Close
27.13 - Open
27.27 - Bid 27.78 x 200
- Ask 27.92 x 400
- Day's Range
27.27 - 28.28 - 52 Week Range
25.69 - 77.14 - Volume
374,418 - Avg. Volume
568,928 - Market Cap (intraday)
1.279B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
-- - EPS (TTM)
-0.45 - Earnings Date May 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
34.50
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
www.omnicell.com3,650
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OMCL
Performance Overview: OMCL
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OMCL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OMCL
Valuation Measures
Market Cap
1.28B
Enterprise Value
1.41B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.10
Price/Book (mrq)
1.08
Enterprise Value/Revenue
1.23
Enterprise Value/EBITDA
23.29
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.78%
Return on Assets (ttm)
-0.61%
Return on Equity (ttm)
-1.76%
Revenue (ttm)
1.15B
Net Income Avi to Common (ttm)
-20.37M
Diluted EPS (ttm)
-0.45
Balance Sheet and Cash Flow
Total Cash (mrq)
467.97M
Total Debt/Equity (mrq)
51.65%
Levered Free Cash Flow (ttm)
114.58M
Research Analysis: OMCL
Company Insights: OMCL
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: OMCL
OMCL: Raising target price to $23.00
OMNICELL INC has an Investment Rating of SELL; a target price of $23.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetOMCL: Lowering target price to $21.00
OMNICELL INC has an Investment Rating of SELL; a target price of $21.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetOMCL: Raising target price to $23.00
OMNICELL INC has an Investment Rating of SELL; a target price of $23.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetOMCL: What does Argus have to say about OMCL?
OMNICELL INC has an Investment Rating of SELL; a target price of $22.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target